Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ ReductionAndrew W. Stamford, William J. Greenlee, Sarah W. Li et al.|ACS Medicinal Chemistry Letters|2012Cited by 99
Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein InhibitorXiufang Zheng, Hongying Yun, Lu Gao et al.|Journal of Medicinal Chemistry|2019Cited by 96